The second group (liraglutide, dulaglutide and semaglutide) have a modified human GLP-1 structure and, hence, a much closer homology to that of GLP-1 itself
It was originally developed at Washington State University and has been patented for potential use in Alzheimer's disease and other neurodegenerative conditions
K., & Abraham, N
Doi:10.1038/s41591-023-02597-w Aronne LJ, Sattar N, Horn DB, et al
The nasal mucosa has a rich blood supply and a direct link to the central nervous system
In-person consultations can take place at our clinic " Halo Health, 16 Station Road, Knowle, Solihull, B93 0HT " by appointment, providing a personalised and private clinical environment